Nemvaleukin showed promising antitumor activity and manageable safety in advanced solid tumors, both alone and with pembrolizumab. ARTISTRY-1 study included dose-escalation, dose-expansion, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback